Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers.
Schistosoma haematobium is the leading cause of urogenital schistosomiasis and it is recognised as a class 1 carcinogen due to the robust association of infection with bladder cancer. In schistosomes, tetraspanins (TSPs) are abundantly present in different parasite proteomes and could be potential d...
Saved in:
Main Authors: | Gebeyaw G Mekonnen (Author), Bemnet A Tedla (Author), Mark S Pearson (Author), Luke Becker (Author), Matt Field (Author), Abena S Amoah (Author), Govert van Dam (Author), Paul L A M Corstjens (Author), Takafira Mduluza (Author), Francisca Mutapi (Author), Alex Loukas (Author), Javier Sotillo (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.
by: Javier Sotillo, et al.
Published: (2019) -
Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
by: Kate M Mitchell, et al.
Published: (2014) -
Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children.
by: Derick N M Osakunor, et al.
Published: (2020) -
Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.
by: Laura J Appleby, et al.
Published: (2012) -
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011)